Depletion of JARID1B induces cellular senescence in human colorectal cancer

International Journal of Oncology

Volumn 42, Issue 4, 2013, Pages 1212-1218

  Ohta, Katsuya ^a   Haraguchi, Naotsugu ^a   Kano, Yoshihiro ^a   Kagawa, Yoshinori ^a   Konno, Masamitsu ^a   Nishikawa, Shimpei ^a   Hamabe, Atsushi ^a   Hasegawa, Shinichiro ^a   Ogawa, Hisataka ^a   Fukusumi, Takahito ^a   Uemura, Mamoru ^a   Nishimura, Junichi ^a   Hata, Taishi ^a   Takemasa, Ichiro ^a   Mizushima, Tsunekazu ^a   Noguchi, Yuko ^a   Ozaki, Miyuki ^a   Kudo, Toshihiro ^a   Sakai, Daisuke ^a   Satoh, Taroh ^a   Fukami, Miwa ^b,c   Ishii, Masaru ^b,c   Yamamoto, Hirofumi ^a   Doki, Yuichiro ^a   Mori, Masaki ^a   Ishii, Hideshi ^a   more..

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

AT rich interactive domain 1B; Cellular senescence; Colorectal cancer; Epigenome; H3K4 demethylase; Jumonji; Tumor suppressor genes

Indexed keywords

ALDEHYDE DEHYDROGENASE; BETA GALACTOSIDASE; CD20 ANTIGEN; CYCLIN DEPENDENT KINASE INHIBITOR 2A; HERMES ANTIGEN; HISTONE DEMETHYLASE; HISTONE DEMETHYLASE JARID1B; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CARCINOGENICITY; CELL AGING; CELL DIFFERENTIATION; CELL POPULATION; CELL PROLIFERATION; CELL TRACKING; COLORECTAL CANCER; CONTROLLED STUDY; ENZYME ACTIVITY; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; INOCULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SENESCENCE; STEM CELL;

ADENOCARCINOMA; ANIMALS; ANTIGENS, CD20; CELL AGING; CELL LINE, TUMOR; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; COLORECTAL NEOPLASMS; GENE KNOCKDOWN TECHNIQUES; HUMANS; JUMONJI DOMAIN-CONTAINING HISTONE DEMETHYLASES; MICE; MICE, INBRED NOD; MICE, SCID; NEOPLASM TRANSPLANTATION; NEOPLASTIC STEM CELLS; NUCLEAR PROTEINS; REPRESSOR PROTEINS; RNA, SMALL INTERFERING; TUMOR BURDEN;

EID: 84874615877     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2013.1799     Document Type: Article

References (25)

1. Markowitz SD and Bertagnolli MM: Molecular origins of cancer: Molecular basis of colorectal cancer. N Engl J Med 361:2449-2460, 2009.
2. Patai AV, Molnár B, Kalmár A, Schöller A, Tóth K and Tulassay Z: Role of DNA methylation in colorectal carcinogenesis. Dig Dis 30:310-315, 2012.
3. Gargalionis AN, Piperi C, Adamopoulos C and Papavassiliou AG: Histone modifications as a pathogenic mechanism of colorectal tumorigenesis. Int J Biochem Cell Biol 44:1276-1289, 2012.
4. Brabletz T, Jung A, Spaderna S, Hlubek F and Kirchner T: Opinion: migrating cancer stem cells-an integrated concept of malignant tumour progression. Nat Rev Cancer 5:744-749, 2005.
5. Kouzarides T: Chromatin modifications and their function. Cell 128:693-705, 2007.
6. Roesch A, Fukunaga-Kalabis M, Schmidt EC, et al: A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth. Cell 141:583-594, 2010.
7. Sakaue-Sawano A, Kurokawa H, Morimura T, et al: Visualizing spatiotemporal dynamics of multicellular cell-cycle progression. Cell 132:487-498, 2008.
8. Haraguchi N, Ishii H, Mimori K, et al: CD13 is a therapeutic target in human liver cancer stem cells. J Clin Invest 120:3326-3339, 2010.
9. Takahashi A, Imai Y, Yamakoshi K, et al: DNA damage signaling triggers degradation of histone methyltransferases through APC/C (Cdh1) in senescent cells. Mol Cell 45:123-131, 2012.
10. Yamane K, Tateishi K, Klose RJ, et al: PLU-1 is an H3K4 demethylase involved in transcriptional repression and breast cancer cell proliferation. Mol Cell 25:801-812, 2007.
11. Xiang Y, Zhu Z, Han G, et al: JARID1B is a histone H3 lysine 4 demethylase up-regulated in prostate cancer. Proc Natl Acad Sci USA 104:19226-19231, 2007.
12. Kastan MB and Bartek J: Cell-cycle checkpoints and cancer. Nature 432:316-323, 2004.
13. Ohtani N, Zebedee Z, Huot TJ, et al: Opposing effects of Ets and Id proteins on p16INK4a expression during cellular senescence. Nature 409:1067-1070, 2001.
14. Rayess H, Wang MB and Srivatsan ES: Cellular senescence and tumor suppressor gene p16. Int J Cancer 130:1715-1725, 2012.
15. Zhang X, Wu X, Tang W and Luo Y: Loss of p16 (Ink4a) function rescues cellular senescence induced by telomere dysfunction. Int J Mol Sci 13:5866-5877, 2012.
16. Vurusaner B, Poli G and Basaga H: Tumor suppressor genes and ROS: complex networks of interactions. Free Radic Biol Med 52:7-18, 2012.
17. Reya T, Morrison SJ, Clarke MF and Weissman IL: Stem cells, cancer and cancer stem cells. Nature 414:105-111, 2001.
18. Dewi DL, Ishii H, Kano Y, et al: Cancer stem cell theory in gastrointestinal malignancies: recent progress and upcoming challenges. J Gastroenterol 46:1145-1157, 2011.
19. Hanahan D and Weinberg RA: Hallmarks of cancer: the next generation. Cell 144:646-674, 2011.
20. Chicas A, Kapoor A, Wang X, et al: H3K4 demethylation by Jarid1a and Jarid1b contributes to retinoblastoma-mediated gene silencing during cellular senescence. Proc Natl Acad Sci USA 109:8971-8976, 2012.
21. Maruyama J, Naguro I, Takeda K and Ichijo H: Stress-activated MAP kinase cascades in cellular senescence. Curr Med Chem 16:1229-1235, 2009.
22. Rodier F and Campisi J: Four faces of cellular senescence. J Cell Biol 192:547-556, 2011.
23. Ohtani N, Mann DJ and Hara E: Cellular senescence: its role in tumor suppression and aging. Cancer Sci 100:792-797, 2009.
24. Marcato P, Dean CA, Giacomantonio CA and Lee PW: Aldehyde dehydrogenase: its role as a cancer stem cell marker comes down to the specific isoform. Cell Cycle 10:1378-1384, 2011.
25. Yamamoto T, Nakatani M, Narukawa K and Obika S: Antisense drug discovery and development. Future Med Chem 3:339-365, 2011.